The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.
Related Posts
He Worked at the Charlotte Observer. Now He Wants to Buy It.
Local entrepreneur Ted Williams offered a detailed plan to revitalize the paper, complete with a budget.
Estée Lauder’s Longtime CEO Fabrizio Freda to Retire
Fabrizio Freda will retire next year and the beauty company says its board is searching for its next leader.
Financial Services Roundup: Market Talk
Find insight on Hong Kong Exchanges & Clearing, St. James’s Place, Man Group and more in the latest Market Talks covering Financial Services.